State Street
SRTA

State Street’s Strata Critical Medical Inc SRTA Stock Holding History

State Street’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.03M Buy
1,524,390
+178,315
+13% +$938K ﹤0.01% 2795
2026
Q1 		$5.63M Buy
1,346,075
+14,563
+1% +$70.1K ﹤0.01% 2906
2025
Q4 		$6.4M Buy
1,331,512
+25,096
+2% +$121K ﹤0.01% 2872
2025
Q3 		$6.61M Buy
1,306,416
+12,760
+1% +$56.4K ﹤0.01% 2870
2025
Q2 		$5.21M Buy
1,293,656
+32,605
+3% +$106K ﹤0.01% 2925
2025
Q1 		$3.44M Sell
1,261,051
-12,086
-0.9% -$43.4K ﹤0.01% 3033
2024
Q4 		$5.41M Sell
1,273,137
-7,705
-0.6% -$29.3K ﹤0.01% 2932
2024
Q3 		$3.77M Buy
1,280,842
+31,313
+3% +$99.7K ﹤0.01% 3091
2024
Q2 		$4.35M Buy
1,249,529
+76,071
+6% +$254K ﹤0.01% 2985
2024
Q1 		$3.34M Buy
1,173,458
+3,735
+0.3% +$11.5K ﹤0.01% 3095
2023
Q4 		$4.13M Sell
1,169,723
-852,595
-42% -$2.45M ﹤0.01% 3036
2023
Q3 		$5.24M Sell
2,022,318
-16,426
-0.8% -$57.7K ﹤0.01% 2892
2023
Q2 		$8.03M Buy
2,038,744
+785,343
+63% +$2.49M ﹤0.01% 2763
2023
Q1 		$4.24M Buy
1,253,401
+38,720
+3% +$158K ﹤0.01% 3050
2022
Q4 		$4.35M Sell
1,214,681
-9,477
-0.8% -$40.5K ﹤0.01% 3094
2022
Q3 		$4.93M Sell
1,224,158
-605,220
-33% -$3.11M ﹤0.01% 3068
2022
Q2 		$8.16M Sell
1,829,378
-1,058,082
-37% -$7.64M ﹤0.01% 2849
2022
Q1 		$24.5M Sell
2,887,460
-240,361
-8% -$1.69M ﹤0.01% 2256
2021
Q4 		$27.6M Buy
3,127,821
+2,977,621
+1,982% +$28.3M ﹤0.01% 2232
2021
Q3 		$1.56M Buy
150,200
+13,500
+10% +$118K ﹤0.01% 3678
2021
Q2 		$1.44M Buy
+136,700
New +$1.35M ﹤0.01% 3604

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street's SRTA Position: Q2 2026 in Review

State Street increased its Strata Critical Medical Inc (SRTA) stake by 13% in Q2 2026, buying an estimated $938K and bringing the position to 1,524,390 shares worth $8.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2795.

State Street first reported a position in SRTA in Q2 2021 and has held it in 21 quarters since. The position peaked at $27.6M in Q4 2021. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • State Street held 1,524,390 shares of Strata Critical Medical Inc worth $8.03M as of Q2 2026.
  • State Street bought 178,315 Strata Critical Medical Inc shares in Q2 2026, an estimated $938K.
  • Strata Critical Medical Inc made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2795 holding.
  • State Street first reported a position in Strata Critical Medical Inc in Q2 2021 and has held it in 21 quarters since.
  • State Street's Strata Critical Medical Inc position peaked at $27.6M in Q4 2021.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.